Slowing of brain atrophy and reductions in new multiple sclerosis lesions sustained at three years in patients treated with Genzyme's LemtradaTM
Genzyme, 30 Apr 2014
Accessed on 15 May 2014 from http://news.genzyme.com/press-release/slowing-brain-atrophy-and-reductions-new-multiple-sclerosis-lesions-sustained-three-ye.